Neoadjuvant biomarker trial of pepinemab to enhance nivolumab or ipilimumab activity in resectable head and neck cancer.

Authors: Conor Ernst Steuer, Elizabeth E. Evans, Terrence Lee Fisher, Crystal L. Mallow, Nicole Cherie Schmitt, Amber Foster, Elaine Gersz, Maria Scrivens, Jacklyn Hammons, Ellen Giampoli, Erin Grundy, Daniel Lubin, Yuan Liu, Mihir R. Patel, Chrystal M. Paulos, Gregory B. Lesinski, Maurice Zauderer, Nabil F. Saba

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.103

Source: Full article

---

Abstract

103